Nov 5 (Reuters) - Pfizer (PFE.N) plans to sweeten its bid for Metsera (MTSR.O), a person familiar with the matter told ...

The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...

Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks' rare disease treatment may never have reached patients. Pharmas ...

Novo Nordisk, maker of Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time, citing slower growth in diabetes and obesity treatments ...

LONDON (Reuters) -Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its ...

Dr. Dansey, formerly of Pfizer and Seagen, strengthens the Board’s research, drug development and commercialization expertise ...

Dow Jones Top Company Headlines at 11 AM ET: Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera | Pfizer ... Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss ...

Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.

Dow Jones Top Company Headlines at 9 AM ET: Pfizer Profit Falls Amid Lower Covid-19 Drug Demand | Hormel ... Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral ...

Donald Trump engages in ad hoc agreements with individual companies and governments to expand his power. Some observers have described these actions as a new “economic nationalism”—but that term fails ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

NFL stars Travis and Jason Kelce have amassed significant wealth beyond their playing careers. Travis, still active with the Chiefs, boasts an estimated $90 million net worth from contracts and ...